2023-03-13 04:53:55 ET
- Novartis ( NYSE: NVS ) started a new stock buyback program to repurchase up to CHF10B ($10.9B) worth of its shares across three years, Reuters reported.
- The Swiss pharma giant plans to purchase up to 10% of its shares from March 7, 2023 (the date of its Annual General Meeting - AGM) to its next AGM in 2026.
- At the company's AGM, the company's stockholders approved carrying forward the the remaining share repurchase authorization of CHF6.5B. The amount was extended to up to CHF10B in total, the report added .
For further details see:
Novartis launches CHF10B stock buyback program